APUS vs COST · $2.4M cap vs P/E 55, rev $275.24B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
APUS does not have a complete income-statement cache yet.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
APUS currently screens at market cap $2.4M. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the APUS and COST stock pages for the full models.
Not investment advice.